PanaCura Inc.
- Biotech or pharma, therapeutic R&D
- CMO, CRO
- Medical device or technology
- Biotech – food & agriculture
PanaCura Inc. is a company that develops therapeutic treatments for Stroke, cancer, diabetes, obesity, COPD, asthma, and skin diseases with various active compounds founded from natural products and holds patents. Shareholders are Professors graduated and postdoctoral course from Johns Hopkins University and NIH. It is a participating shareholder with stem cell, cancer, skin disease, and nano-convergence research.
경희청혈단 (NeuroRescueX, NRX) is a complex herbal medicine, in capsule form, derived from an 80% ethanol extraction of herbs in Kyung Hee Univ. Korean Medicine Hospital's leading. NRX inhibits 3-hydroxy-3-meth- ylglutaryl (HMG) coenzyme A (CoA) reductase[15] and improves arterial stiffness.[16] It also has anti-inflammatory[17] and antilip- idemic effects,[18] which are due to the activation of NO produc- tion and the inhibition of VCAM-1 expression in endothelial cells.[19] In addition, antihypertensive,[20] anti-oxidative[17] and anti-apoptotic effects[21] have been verified.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}